AbbVie shares jump as results beat expectations despite blockbuster Humira’s declining sales
July 27, 2023 at 11:15 AM EDT
Newer immunology drugs Skyrizi and Rinvoq boost sales in second quarter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|